BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16630185)

  • 1. Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases.
    Dettrick A; Strutton G
    J Cutan Pathol; 2006 Apr; 33(4):318-22. PubMed ID: 16630185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical fibroxanthoma and malignant fibrous histiocytoma.
    Withers AH; Brougham ND; Barber RM; Tan ST
    J Plast Reconstr Aesthet Surg; 2011 Nov; 64(11):e273-8. PubMed ID: 21664889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Gleason BC; Fletcher CD
    Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
    Ziemer M; Jäger IM; Dippel E
    Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
    Hartel PH; Jackson J; Ducatman BS; Zhang P
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
    Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
    Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; Stańczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
    Beer TW; Drury P; Heenan PJ
    Am J Dermatopathol; 2010 Aug; 32(6):533-40. PubMed ID: 20526171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular neurothekeoma: detailed characterization in a series of 133 cases.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):329-40. PubMed ID: 17325474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent atypical fibroxanthoma of the cheek.
    Skoulas IG; Price M; Andrew JE; Kountakis SE
    Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
    Beer TW; Haig D
    Am J Dermatopathol; 2009 Oct; 31(7):649-52. PubMed ID: 19652583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
    Branch LG; Albertini JG; Leshin B
    J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience.
    McCoppin HH; Christiansen D; Stasko T; Washington C; Martinez JC; Brown MD; Zwald FO
    Dermatol Surg; 2012 Feb; 38(2):230-9. PubMed ID: 22129349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma simulating atypical fibroxanthoma.
    Sangüeza M; Zelger B
    Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
    Rizzardi C; Angiero F; Melato M
    Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.